| A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York City JA Frontera, S Sabadia, R Lalchan, T Fang, B Flusty, P Millar-Vernetti, ... Neurology 96 (4), e575-e586, 2021 | 329 | 2021 |
| Autosomal dominant cerebellar ataxias: a systematic review of clinical features M Rossi, S Perez‐Lloret, L Doldan, D Cerquetti, J Balej, P Millar Vernetti, ... European Journal of Neurology 21 (4), 607-615, 2014 | 155 | 2014 |
| Validation of a new scale to assess olfactory dysfunction in patients with Parkinson’s disease PM Vernetti, SP Lloret, M Rossi, D Cerquetti, M Merello Parkinsonism & related disorders 18 (4), 358-361, 2012 | 59 | 2012 |
| The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension JA Palma, G Redel-Traub, A Porciuncula, D Samaniego-Toro, PM Vernetti, ... Parkinsonism & related disorders 75, 97-104, 2020 | 43 | 2020 |
| Transcranial magnetic resonance-guided focused ultrasound thalamotomy in essential tremor: a comprehensive lesion characterization JA Pineda-Pardo, D Urso, R Martínez-Fernández, R Rodríguez-Rojas, ... Neurosurgery 87 (2), 256-265, 2020 | 40 | 2020 |
| Genetic dystonia‐ataxia syndromes: clinical spectrum, diagnostic approach, and treatment options M Rossi, B Balint, P Millar Vernetti, KP Bhatia, M Merello Movement Disorders Clinical Practice 5 (4), 373-382, 2018 | 30 | 2018 |
| Olfactory D ysfunction E valuation I s N ot A ffected by C omorbid D epression in P arkinson's D isease M Rossi, S Perez‐Lloret, P Millar Vernetti, L Drucaroff, E Costanzo, ... Movement Disorders 30 (9), 1275-1279, 2015 | 23 | 2015 |
| Limitations of the Unified Multiple System Atrophy Rating Scale as outcome measure for clinical trials and a roadmap for improvement JA Palma, PM Vernetti, MA Perez, F Krismer, K Seppi, A Fanciulli, ... Clinical Autonomic Research 31, 157-164, 2021 | 22 | 2021 |
| Motor features in Parkinson's disease with normal olfactory function M Rossi, AM Escobar, A Bril, P Millar Vernetti, JI De Palo, D Cerquetti, ... Movement Disorders 31 (9), 1414-1417, 2016 | 22 | 2016 |
| Life stressors significantly impact long-term outcomes and post-acute symptoms 12-months after COVID-19 hospitalization JA Frontera, S Sabadia, D Yang, A de Havenon, S Yaghi, A Lewis, ... Journal of the neurological sciences 443, 120487, 2022 | 19 | 2022 |
| mTOR inhibition with Sirolimus in multiple system atrophy: a randomized, double‐blind, placebo‐controlled futility trial and 1‐year biomarker longitudinal analysis JA Palma, J Martinez, P Millar Vernetti, T Ma, MA Perez, J Zhong, Y Qian, ... Movement Disorders 37 (4), 778-789, 2022 | 19 | 2022 |
| Diagnostic value of combined acute levodopa challenge and olfactory testing to predict Parkinson's disease C Terroba Chambi, M Rossi, A Bril, PM Vernetti, D Cerquetti, ... Movement Disorders Clinical Practice 4 (6), 824-828, 2017 | 14 | 2017 |
| Comparison of olfactory identification patterns among Parkinson’s disease patients from different countries P Millar Vernetti, M Rossi, D Cerquetti, S Perez Lloret, M Merello Chemical senses 41 (1), 77-83, 2016 | 13 | 2016 |
| Design and validation of a new instrument to assess fear of falling in Parkinson's disease C Terroba‐Chambi, V Bruno, P Millar‐Vernetti, D Bruce, S Brockman, ... Movement disorders 34 (10), 1496-1504, 2019 | 12 | 2019 |
| A multifactorial study on nutritional status, binge eating and physical activity as main factors directly influencing body weight in Parkinson’s disease A Bril, S Perez-Lloret, M Rossi, S Fariña, P Morisset, L Sorrentino, ... npj Parkinson's Disease 3 (1), 17, 2017 | 10 | 2017 |
| Afferent baroreflex dysfunction: decreased or excessive signaling results in distinct phenotypes L Norcliffe-Kaufmann, PM Vernetti, JA Palma, BJ Balgobin, H Kaufmann Seminars in Neurology 40 (05), 540-549, 2020 | 7 | 2020 |
| Traumatic vs Spontaneous Cerebrospinal Fluid Hypotension Headache: Our experience in a series of 137 cases F Villamil, M Ruella, A Perez, PM Vernetti, MEP Formenti, JN Acosta, ... Clinical Neurology and Neurosurgery 198, 106140, 2020 | 6 | 2020 |
| Genetic diagnosis in movement disorders. Use of whole-exome sequencing in clinical practice PM Vernetti, MAR Yanzi, M Rossi, M Merello Tremor and Other Hyperkinetic Movements 12, 2022 | 4 | 2022 |
| Parkin pleiotropy: extremely atypical phenotypes in patients with compound heterozygous mutations PM Vernetti, M Rossi, M Merello Tremor and Other Hyperkinetic Movements 10, 2020 | 3 | 2020 |
| Meropenem‐induced facial myoclonus P Millar Vernetti, K Dalamo, Z Khan, A Gonzalez‐Duarte, S Frucht, ... Movement Disorders Clinical Practice 10, S21-S23, 2023 | 2 | 2023 |
